Loading...

Home
ETF
ONCO

ONCO

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ONCO News

Realbotix Enters All-Stock Acquisition Agreement with Onconetix

3d agoseekingalpha

ANDREW KIGUEL TO ASSUME CEO ROLE OF MERGED COMPANY AFTER CLOSURE, SAYS ONCONETIX INC.

REALBOTIX CORP - ONCONETIX ACQUIRES FULL OWNERSHIP OF REALBOTIX, LLC THROUGH STOCK TRANSACTION

ONCONETIX INC - FOLLOWING DEAL CLOSURE, REALBOTIX PARENT WILL ACQUIRE 75% TO 90% OF FULLY DILUTED COMMON SHARES IN THE COMBINED ENTITY

ONCONETIX INC TO PURCHASE 100% OF REALBOTIX'S ISSUED AND OUTSTANDING EQUITY INTERESTS THROUGH AN ALL-STOCK DEAL

ONCONETIX SET TO PURCHASE REALBOTIX LLC, AN AI-DRIVEN HUMANOID ROBOTICS FIRM BASED IN THE USA

Authparency.ai Wins First Prize at Southlake Innovation Cup for Solving Healthcare Authorization Issues

Dec 30 2025Yahoo Finance

Onconetix Secures $12.9 Million in Financing via Series D Preferred Stock and Warrants, Ends Merger Agreement with Ocuvex, Inc., and Settles $8.8 Million Debt with Veru, Inc.

Sep 26 2025Newsfilter

Joint Announcement: Onconetix and Ocuvex Declare End of Merger Agreement

Sep 26 2025Newsfilter

Why Meta Platforms Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Jul 31 2025Benzinga

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ONCO, WAT, XAGE on Behalf of Shareholders

Jul 18 2025PRnewswire

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Onconetix, Inc. (NASDAQ: ONCO)

Jul 17 2025Globenewswire

Dow Surges Over 100 Points; Goldman Sachs Posts Upbeat Earnings

Jul 16 2025Benzinga

US Stocks Mixed; Bank of America Earnings Top Views

Jul 16 2025Benzinga

Onconetix To Merge With Ocuvex Therapeutics

Jul 16 2025NASDAQ.COM

Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement

Jul 16 2025Yahoo Finance